TLRY280121C00005000
TLRY Jan 21 2028 5.00 Call
optionOPRA
EODOct 7, 2026
1.05USD+0.962%(+0.01)200Vol2,456OI
Loading…
Underlying
Underlying Price
$3.61
Type
Call
Strike
5
Expiration
Jan 21, 2028
DTE
469d
Moneyness
OTM
Intrinsic
$0.00
TLRY 5 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 9, 2026 | 0d | $0.02 | +0.00% | 142 | 1,174 |
| Oct 16, 2026 | 7d | $0.04 | +33.33% | 313 | 5,777 |
| Oct 23, 2026 | 14d | $0.04 | -20.00% | 1 | 680 |
| Oct 30, 2026 | 21d | $0.07 | -12.50% | 3 | 523 |
| Nov 6, 2026 | 28d | $0.08 | -11.11% | 506 | 352 |
| Nov 13, 2026 | 35d | $0.08 | +0.00% | 2 | 9 |
| Nov 20, 2026 | 42d | $0.10 | -16.67% | 2,510 | 3,880 |
| Nov 27, 2026 | 49d | — | — | 0 | 0 |
| Dec 18, 2026 | 70d | $0.18 | -5.26% | 50 | 1,336 |
| Jan 15, 2027 | 98d | $0.01 | +0.00% | 1 | 9,849 |
| Jan 15, 2027 | 98d | $0.25 | -7.41% | 16 | 9,635 |
| Mar 19, 2027 | 161d | $0.41 | +2.50% | 32 | 340 |
| Jan 21, 2028 | 469d | $0.05 | +25.00% | 50 | 2,756 |
| Jan 21, 2028 | 469d | $1.05 | +0.96% | 200 | 2,456 |
| Jan 19, 2029 | 833d | $1.53 | +9.29% | 1 | 10 |
TLRY Nearby Strikes · Jan 21, 2028
| Strike | Last | Change | Vol | Open Int | Moneyness |
|---|---|---|---|---|---|
| 3.5 C | $0.01 | +0.00% | 1 | 563 | ITM |
| 3.5 C | $1.32 | -23.70% | 2 | 30 | ITM |
| 4 C | $0.03 | -40.00% | 78 | 21,076 | OTM |
| 4 C | $1.32 | -0.75% | 3 | 1,595 | OTM |
| 4.5 C | $1.06 | +9.28% | 42 | 766 | OTM |
| 4.5 C | $0.02 | +100.00% | 18 | 105 | OTM |
| 5 C | $0.05 | +25.00% | 50 | 2,756 | OTM |
| 5 C | $1.05 | +0.96% | 200 | 2,456 | OTM |
| 5.5 C | $0.94 | -1.05% | 1 | 413 | OTM |
| 7 C | $0.63 | -19.23% | 6 | 2,143 | OTM |
| 7 C | $0.01 | +0.00% | 10 | 1,071 | OTM |
| 10 C | $0.42 | +0.00% | 1 | 1,752 | OTM |
| 12 C | $0.35 | +2.94% | 45 | 823 | OTM |
TLRY Profile
tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. we are the only gmp certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in australia, canada, the european union and the americas.